ICH Q13 at three years: continuous manufacturing uptake in 2026
Three years after ICH Q13 came into force, 17 continuous-manufacturing drug approvals sit on the FDA's ledger and 72 CM technologies have joined the Emerging Technology Program - but adoption remains narrow.